Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 7038603, 11 pages
https://doi.org/10.1155/2017/7038603
Research Article

Pleiotropic Effects of Biguanides on Mitochondrial Reactive Oxygen Species Production

Institute of Physiology of the Czech Academy of Sciences, Vídeňská, 1083 Prague, Czech Republic

Correspondence should be addressed to Tomas Mracek; zc.sac.ugf@kecarm.samot

Received 29 March 2017; Accepted 13 June 2017; Published 9 August 2017

Academic Editor: Jacek Zielonka

Copyright © 2017 Alena Pecinova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Bosi, “Metformin—the gold standard in type 2 diabetes: what does the evidence tell us?” Diabetes, Obesity & Metabolism, vol. 11, Supplement 2, pp. 3–8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. R. K. Campbell, J. R. White Jr., and B. A. Saulie, “Metformin: a new oral biguanide,” Clinical Therapeutics, vol. 18, no. 3, pp. 360–371, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. W. C. Knowler, E. Barrett-Connor, S. E. Fowler et al., “Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin,” The New England Journal of Medicine, vol. 346, no. 6, pp. 393–403, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. R. A. Miller, Q. Chu, J. Xie, M. Foretz, B. Viollet, and M. J. Birnbaum, “Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP,” Nature, vol. 494, no. 7436, pp. 256–260, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. Q. Wang, M. Zhang, G. Torres et al., “Metformin suppresses diabetes-accelerated atherosclerosis via the inhibition of Drp1-mediated mitochondrial fission,” Diabetes, vol. 66, no. 1, pp. 193–205, 2017. View at Publisher · View at Google Scholar
  6. K. Forslund, F. Hildebrand, T. Nielsen et al., “Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota,” Nature, vol. 528, no. 7581, pp. 262–266, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. A. K. Madiraju, D. M. Erion, Y. Rahimi et al., “Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase,” Nature, vol. 510, no. 7506, pp. 542–546, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. M. R. Owen, E. Doran, and A. P. Halestrap, “Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain,” The Biochemical Journal, vol. 348, no. 3, pp. 607–614, 2000. View at Publisher · View at Google Scholar
  9. G. Zhou, R. Myers, Y. Li et al., “Role of AMP-activated protein kinase in mechanism of metformin action,” The Journal of Clinical Investigation, vol. 108, no. 8, pp. 1167–1174, 2001. View at Publisher · View at Google Scholar
  10. Z. Drahota, E. Palenickova, R. Endlicher et al., “Biguanides inhibit complex I, II and IV of rat liver mitochondria and modify their functional properties,” Physiological Research, vol. 63, no. 1, pp. 1–11, 2014. View at Google Scholar
  11. M. Foretz, B. Guigas, L. Bertrand, M. Pollak, and B. Viollet, “Metformin: from mechanisms of action to therapies,” Cell Metabolism, vol. 20, no. 6, pp. 953–966, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. D. T. Eurich, S. R. Majumdar, F. A. McAlister, R. T. Tsuyuki, and J. A. Johnson, “Improved clinical outcomes associated with metformin in patients with diabetes and heart failure,” Diabetes Care, vol. 28, no. 10, pp. 2345–2351, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. F. A. Masoudi, S. E. Inzucchi, Y. Wang, E. P. Havranek, J. M. Foody, and H. M. Krumholz, “Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study,” Circulation, vol. 111, no. 5, pp. 583–590, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Sun and F. Yang, “Metformin improves cardiac function in mice with heart failure after myocardial infarction by regulating mitochondrial energy metabolism,” Biochemical and Biophysical Research Communications, vol. 486, no. 2, pp. 329–335, 2017. View at Publisher · View at Google Scholar
  15. J. Benes, L. Kazdova, Z. Drahota et al., “Effect of metformin therapy on cardiac function and survival in a volume-overload model of heart failure in rats,” Clinical Science, vol. 121, no. 1, pp. 29–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Decensi, M. Puntoni, P. Goodwin et al., “Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis,” Cancer Prevention Research, vol. 3, no. 11, pp. 1451–1461, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Libby, L. A. Donnelly, P. T. Donnan, D. R. Alessi, A. D. Morris, and J. M. Evans, “New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes,” Diabetes Care, vol. 32, no. 9, pp. 1620–1625, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Pollak, “Potential applications for biguanides in oncology,” The Journal of Clinical Investigation, vol. 123, no. 9, pp. 3693–3700, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Pollak, “The insulin and insulin-like growth factor receptor family in neoplasia: an update,” Nature Reviews Cancer, vol. 12, no. 3, pp. 159–169, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Griss, E. E. Vincent, R. Egnatchik et al., “Metformin antagonizes cancer cell proliferation by suppressing mitochondrial-dependent biosynthesis,” PLoS Biology, vol. 13, no. 12, article e1002309, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Liu, I. L. Romero, L. M. Litchfield, E. Lengyel, and J. W. Locasale, “Metformin targets central carbon metabolism and reveals mitochondrial requirements in human cancers,” Cell Metabolism, vol. 24, no. 5, pp. 728–739, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Y. El-Mir, V. Nogueira, E. Fontaine, N. Averet, M. Rigoulet, and X. Leverve, “Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I,” The Journal of Biological Chemistry, vol. 275, no. 1, pp. 223–228, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. H. R. Bridges, A. J. Jones, M. N. Pollak, and J. Hirst, “Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria,” The Biochemical Journal, vol. 462, no. 3, pp. 475–487, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. W. W. Wheaton, S. E. Weinberg, R. B. Hamanaka et al., “Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis,” eLife, vol. 3, article e02242, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Viollet, B. Guigas, N. Sanz Garcia, J. Leclerc, M. Foretz, and F. Andreelli, “Cellular and molecular mechanisms of metformin: an overview,” Clinical Science, vol. 122, no. 6, pp. 253–270, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Liu, R. R. Chhipa, S. Pooya et al., “Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 4, pp. E435–E444, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Mracek, E. Holzerova, Z. Drahota et al., “ROS generation and multiple forms of mammalian mitochondrial glycerol-3-phosphate dehydrogenase,” Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1837, no. 1, pp. 98–111, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. A. P. Kudin, N. Y. Bimpong-Buta, S. Vielhaber, C. E. Elger, and W. S. Kunz, “Characterization of superoxide-producing sites in isolated brain mitochondria,” The Journal of Biological Chemistry, vol. 279, no. 6, pp. 4127–4135, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. C. L. Quinlan, J. R. Treberg, I. V. Perevoshchikova, A. L. Orr, and M. D. Brand, “Native rates of superoxide production from multiple sites in isolated mitochondria measured using endogenous reporters,” Free Radical Biology and Medicine, vol. 53, no. 9, pp. 1807–1817, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. S. S. Korshunov, V. P. Skulachev, and A. A. Starkov, “High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria,” FEBS Letters, vol. 416, no. 1, pp. 15–18, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. A. J. Lambert and M. D. Brand, “Superoxide production by NADH: ubiquinone oxidoreductase (complex I) depends on the pH gradient across the mitochondrial inner membrane,” The Biochemical Journal, vol. 382, Part 2, pp. 511–517, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Herrero and G. Barja, “Sites and mechanisms responsible for the low rate of free radical production of heart mitochondria in the long-lived pigeon,” Mechanisms of Ageing and Development, vol. 98, no. 2, pp. 95–111, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Hirst, M. S. King, and K. R. Pryde, “The production of reactive oxygen species by complex I,” Biochemical Society Transactions, vol. 36, Part 5, pp. 976–980, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. C. L. Quinlan, A. L. Orr, I. V. Perevoshchikova, J. R. Treberg, B. A. Ackrell, and M. D. Brand, “Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions,” The Journal of Biological Chemistry, vol. 287, no. 32, pp. 27255–27264, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. Z. Drahota, S. K. Chowdhury, D. Floryk et al., “Glycerophosphate-dependent hydrogen peroxide production by brown adipose tissue mitochondria and its activation by ferricyanide,” Journal of Bioenergetics and Biomembranes, vol. 34, no. 2, pp. 105–113, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Mracek, A. Pecinova, M. Vrbacky, Z. Drahota, and J. Houstek, “High efficiency of ROS production by glycerophosphate dehydrogenase in mammalian mitochondria,” Archives of Biochemistry and Biophysics, vol. 481, no. 1, pp. 30–36, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Vrbacky, Z. Drahota, T. Mracek et al., “Respiratory chain components involved in the glycerophosphate dehydrogenase-dependent ROS production by brown adipose tissue mitochondria,” Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1767, no. 7, pp. 989–997, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Cannon and O. Lindberg, “Mitochondria from brown adipose tissue: isolation and properties,” Methods in Enzymology, vol. 55, pp. 65–78, 1979. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Labajova, A. Vojtiskova, P. Krivakova, J. Kofranek, Z. Drahota, and J. Houstek, “Evaluation of mitochondrial membrane potential using a computerized device with a tetraphenylphosphonium-selective electrode,” Analytical Biochemistry, vol. 353, no. 1, pp. 37–42, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Pecinova, Z. Drahota, H. Nuskova, P. Pecina, and J. Houstek, “Evaluation of basic mitochondrial functions using rat tissue homogenates,” Mitochondrion, vol. 11, no. 5, pp. 722–728, 2011. View at Publisher · View at Google Scholar
  41. H. Schagger and G. von Jagow, “Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa,” Analytical Biochemistry, vol. 166, no. 2, pp. 368–379, 1987. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Mracek, P. Jesina, P. Krivakova et al., “Time-course of hormonal induction of mitochondrial glycerophosphate dehydrogenase biogenesis in rat liver,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1726, no. 2, pp. 217–223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Miyadera, K. Shiomi, H. Ui et al., “Atpenins, potent and specific inhibitors of mitochondrial complex II (succinate-ubiquinone oxidoreductase),” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 2, pp. 473–477, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. A. L. Orr, D. Ashok, M. R. Sarantos et al., “Novel inhibitors of mitochondrial sn-glycerol 3-phosphate dehydrogenase,” PLoS One, vol. 9, no. 2, article e89938, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Houstek, B. Cannon, and O. Lindberg, “Glycerol-3-phosphate shuttle and its function in intermediary metabolism of hamster brown-adipose tissue,” European Journal of Biochemistry, vol. 54, no. 1, pp. 11–18, 1975. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Boukalova, J. Stursa, L. Werner et al., “Mitochondrial targeting of metformin enhances its activity against pancreatic cancer,” Molecular Cancer Therapeutics, vol. 15, no. 12, pp. 2875–2886, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Cheng, J. Zielonka, O. Ouari et al., “Mitochondria-targeted analogues of metformin exhibit enhanced antiproliferative and radiosensitizing effects in pancreatic cancer cells,” Cancer Research, vol. 76, no. 13, pp. 3904–3915, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Mracek, Z. Drahota, and J. Houstek, “The function and the role of the mitochondrial glycerol-3-phosphate dehydrogenase in mammalian tissues,” Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1827, no. 3, pp. 401–410, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Kluckova, M. Sticha, J. Cerny et al., “Ubiquinone-binding site mutagenesis reveals the role of mitochondrial complex II in cell death initiation,” Cell Death & Disease, vol. 6, article e1749, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Rohlena, L. F. Dong, K. Kluckova et al., “Mitochondrially targeted alpha-tocopheryl succinate is antiangiogenic: potential benefit against tumor angiogenesis but caution against wound healing,” Antioxidants & Redox Signaling, vol. 15, no. 12, pp. 2923–2935, 2011. View at Publisher · View at Google Scholar
  51. B. Kalyanaraman, G. Cheng, M. Hardy et al., “Modified metformin as a more potent anticancer drug: mitochondrial inhibition, redox signaling, antiproliferative effects and future EPR studies,” Cell Biochemistry and Biophysics, 2017. View at Publisher · View at Google Scholar
  52. E. Cadenas and K. J. Davies, “Mitochondrial free radical generation, oxidative stress, and aging,” Free Radical Biology and Medicine, vol. 29, no. 3-4, pp. 222–230, 2000. View at Publisher · View at Google Scholar · View at Scopus
  53. Q. Chen, E. J. Vazquez, S. Moghaddas, C. L. Hoppel, and E. J. Lesnefsky, “Production of reactive oxygen species by mitochondria: central role of complex III,” The Journal of Biological Chemistry, vol. 278, no. 38, pp. 36027–36031, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. P. Schonfeld and L. Wojtczak, “Brown adipose tissue mitochondria oxidizing fatty acids generate high levels of reactive oxygen species irrespective of the uncoupling protein-1 activity state,” Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1817, no. 3, pp. 410–418, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. L. Tretter and V. Adam-Vizi, “Generation of reactive oxygen species in the reaction catalyzed by alpha-ketoglutarate dehydrogenase,” The Journal of Neuroscience, vol. 24, no. 36, pp. 7771–7778, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. L. Kussmaul and J. Hirst, “The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 20, pp. 7607–7612, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. C. L. Quinlan, A. A. Gerencser, J. R. Treberg, and M. D. Brand, “The mechanism of superoxide production by the antimycin-inhibited mitochondrial Q-cycle,” The Journal of Biological Chemistry, vol. 286, no. 36, pp. 31361–31372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. I. G. Shabalina, M. Vrbacky, A. Pecinova et al., “ROS production in brown adipose tissue mitochondria: the question of UCP1-dependence,” Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1837, no. 12, pp. 2017–2030, 2014. View at Publisher · View at Google Scholar · View at Scopus